These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 10577386

  • 1. Antisense DNA-targeting protein kinase A-RIA subunit: a novel approach to cancer treatment.
    Cho-Chung YS, Nesterova M, Pepe S, Lee GR, Noguchi K, Srivastava RK, Srivastava AR, Alper O, Park YG, Lee YN.
    Front Biosci; 1999 Dec 01; 4():D898-907. PubMed ID: 10577386
    [Abstract] [Full Text] [Related]

  • 2. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M, Noguchi K, Park YG, Lee YN, Cho-Chung YS.
    Clin Cancer Res; 2000 Sep 01; 6(9):3434-41. PubMed ID: 10999726
    [Abstract] [Full Text] [Related]

  • 3. Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit.
    Nesterova M, Cho-Chung YS.
    Antisense Nucleic Acid Drug Dev; 2000 Dec 01; 10(6):423-33. PubMed ID: 11198926
    [Abstract] [Full Text] [Related]

  • 4. Growth arrest and induction of apoptosis in breast cancer cells by antisense depletion of protein kinase A-RI alpha subunit: p53-independent mechanism of action.
    Srivastava RK, Srivastava AR, Seth P, Agrawal S, Cho-Chung YS.
    Mol Cell Biochem; 1999 May 01; 195(1-2):25-36. PubMed ID: 10395066
    [Abstract] [Full Text] [Related]

  • 5. Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis.
    Tortora G, Caputo R, Damiano V, Bianco R, Fontanini G, Cuccato S, De Placido S, Bianco AR, Ciardiello F.
    Clin Cancer Res; 2001 Aug 01; 7(8):2537-44. PubMed ID: 11489837
    [Abstract] [Full Text] [Related]

  • 6. Antisense DNA toward type I protein kinase A produces sustained inhibition of tumor growth.
    Cho-Chung YS.
    Proc Assoc Am Physicians; 1997 Jan 01; 109(1):23-32. PubMed ID: 9010913
    [Abstract] [Full Text] [Related]

  • 7. The differential response of protein kinase A to cyclic AMP in discrete brain areas correlates with the abundance of regulatory subunit II.
    Ventra C, Porcellini A, Feliciello A, Gallo A, Paolillo M, Mele E, Avvedimento VE, Schettini G.
    J Neurochem; 1996 Apr 01; 66(4):1752-61. PubMed ID: 8627334
    [Abstract] [Full Text] [Related]

  • 8. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis.
    Nesterova MV, Cho-Chung YS.
    Clin Cancer Res; 2004 Jul 01; 10(13):4568-77. PubMed ID: 15240549
    [Abstract] [Full Text] [Related]

  • 9. Experimental gene therapy of human colon cancer.
    Bold RJ, Warren RE, Ishizuka J, Cho-Chung YS, Townsend CM, Thompson JC.
    Surgery; 1994 Aug 01; 116(2):189-95; discussion 195-6. PubMed ID: 8047985
    [Abstract] [Full Text] [Related]

  • 10. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis.
    Nesterova MV, Cho-Chung YS.
    Ann N Y Acad Sci; 2005 Nov 01; 1058():255-64. PubMed ID: 16394142
    [Abstract] [Full Text] [Related]

  • 11. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation.
    Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS.
    Clin Cancer Res; 2002 Feb 01; 8(2):607-14. PubMed ID: 11839683
    [Abstract] [Full Text] [Related]

  • 12. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV, Johnson NR, Stewart T, Abrams S, Cho-Chung YS.
    Clin Cancer Res; 2005 Aug 15; 11(16):5950-5. PubMed ID: 16115938
    [Abstract] [Full Text] [Related]

  • 13. Activated protein kinase A is required for differentiation-dependent transcription of the decidual prolactin gene in human endometrial stromal cells.
    Telgmann R, Maronde E, Taskén K, Gellersen B.
    Endocrinology; 1997 Mar 15; 138(3):929-37. PubMed ID: 9048592
    [Abstract] [Full Text] [Related]

  • 14. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.
    Cho YS, Cho-Chung YS.
    Clin Cancer Res; 2003 Mar 15; 9(3):1171-8. PubMed ID: 12631623
    [Abstract] [Full Text] [Related]

  • 15. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
    Alper O, Hacker NF, Cho-Chung YS.
    Oncogene; 1999 Sep 02; 18(35):4999-5004. PubMed ID: 10490835
    [Abstract] [Full Text] [Related]

  • 16. Nuclear translocation of the catalytic subunit of protein kinase A induced by an antisense oligonucleotide directed against the RIalpha regulatory subunit.
    Neary CL, Cho-Chung YS.
    Oncogene; 2001 Nov 29; 20(55):8019-24. PubMed ID: 11753685
    [Abstract] [Full Text] [Related]

  • 17. Antisense depletion of RIalpha subunit of protein kinase A induces apoptosis and growth arrest in human breast cancer cells.
    Srivastava RK, Srivastava AR, Park YG, Agrawal S, Cho-Chung YS.
    Breast Cancer Res Treat; 1998 May 29; 49(2):97-107. PubMed ID: 9696392
    [Abstract] [Full Text] [Related]

  • 18. Gene regulation of cyclic AMP-dependent protein kinase subunits (C alpha, beta; RI alpha, beta and RII alpha, beta) in rat facial motoneurons after nerve transection.
    Ohno K, Kitahara T, Takeda N, Kubo T, Kiyama H.
    Neuroscience; 1994 Dec 29; 63(4):1101-9. PubMed ID: 7700511
    [Abstract] [Full Text] [Related]

  • 19. The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseases.
    Cho-Chung YS, Clair T.
    Pharmacol Ther; 1993 Nov 29; 60(2):265-88. PubMed ID: 8022860
    [Abstract] [Full Text] [Related]

  • 20. Type II protein kinase A up-regulation is sufficient to induce growth inhibition in SK-N-SH human neuroblastoma cells.
    Kim SN, Lee GR, Hwang ES, Lee JH, Park SD, Cho-Chung YS, Hong SH.
    Biochem Biophys Res Commun; 1997 Mar 17; 232(2):469-73. PubMed ID: 9125203
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.